Document ID: chunk:federal_register_of_legislation:F2021L01582:clause:1_4:p2
Version: federal_register_of_legislation:F2021L01582
Segment Type: clause
Provision Reference: sch 1 cl 4 (pt 2/2)
Character Range: 4447–5390

(b) cannabidiol comprises less than 2% of the total cannabinoid content of the medicine; and
 (c) the medicine contains no other active ingredient.
medicinal cannabis products has the same meaning as in the Regulations.
Regulations means the Therapeutic Goods Regulations 1990.
relevant category, in relation to a medicinal cannabis product, means one of the following categories, as applicable:
 (a) category 1;
 (b) category 2;
 (c) category 3;
 (d) category 4;
 (e) category 5.
SAS B approval means an approval under paragraph 19(1)(a) of the Act.
Note: Paragraph 19(1)(a) of the Act provides that the Secretary may grant an approval for the importation into, or the exportation from, Australia or the supply in Australia of specified therapeutic goods that are not registered goods, listed goods or exempt goods for use in the treatment of another person.
therapeutic goods information has the meaning given by subsection 61(1) of the Act.